Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
Abstract Targeted delivery of drugs to the brain is challenging due to the restricted permeability across the blood brain barrier (BBB). Gliomas are devastating cancers and their positive treatment outcome using Temozolomide (TMZ) is limited due to its short plasma half-life, systemic toxicity and l...
Saved in:
| Main Authors: | Sonali Kumari, Saad M. Ahsan, Jerald M. Kumar, Anand K. Kondapi, Nalam M. Rao |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/183749ab737e48c48f272de1318a8a76 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
by: Zhang J, et al.
Published: (2018) -
Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
by: Shi H, et al.
Published: (2020) -
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
by: Jyotsna U. Rao, et al.
Published: (2017) -
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
by: Peng Y, et al.
Published: (2018) -
Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines
by: Nina Simona Tresch, et al.
Published: (2021)